Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

163
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
163
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

459
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
459
Drug Therapy01:28

Drug Therapy

41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
41
Drug Dependence01:17

Drug Dependence

993
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
993
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

56
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
56
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Future of <i>DSM</i>: Response to Letters.

The American journal of psychiatry·2026
Same author

Failure to Treat Opioid Use Disorder and Opioid Withdrawal Associated with Patient-Directed Discharge in People with Injection-Related Infections.

Journal of general internal medicine·2026
Same author

Medical Toxicology is the Overdose Specialty: Implications for the Dimensions and Continuum of Overdose Care.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Upgrading Housing-First Interventions in the Age of Fentanyl.

JAMA network open·2026
Same author

Developing Longitudinal Post-Overdose Care: A Call to Action.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Welcome to the 2026 ACMT Annual Scientific Meeting.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026

Related Experiment Video

Updated: Jun 21, 2025

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.8K

A Source Control Model for Treatment-Resistant Substance Use Disorder.

Matthew Robert Dernbach1, Karen Drexler, Elizabeth McCord

  • 1From the Departments of Emergency Medicine, and Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA.

Journal of Addiction Medicine
|July 16, 2024
PubMed
Summary
This summary is machine-generated.

This study proposes the "source control" model for treating resistant substance use disorder (SUD), viewing it as a disease. This approach aims to destigmatize SUD and guide innovative multimodal treatments.

More Related Videos

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.5K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K

Related Experiment Videos

Last Updated: Jun 21, 2025

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.8K
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.5K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K

Area of Science:

  • Medical research
  • Public health
  • Addiction medicine

Background:

  • Substance use disorder (SUD) presents complex challenges, particularly in treatment-resistant cases.
  • Current models may not fully address the multifaceted nature of severe SUD.
  • Stigma surrounding SUD hinders effective medical management and patient care.

Purpose of the Study:

  • To introduce and justify the application of the "source control" model to treatment-resistant substance use disorder (SUD).
  • To explore how this conceptual framework can complement existing SUD management strategies.
  • To advance the destigmatization of SUD by framing it as a manageable medical condition.

Main Methods:

  • Conceptual analysis and application of the "source control" model from infectious disease management.
  • Literature review on existing SUD treatment paradigms and challenges.
  • Discussion of the model's strengths, limitations, and potential for future research.

Main Results:

  • The "source control" model offers a novel framework for understanding and managing treatment-resistant SUD.
  • This approach integrates the need for multimodal interventions and acute/long-term care strategies.
  • The model has the potential to stimulate new research directions and therapeutic innovations.

Conclusions:

  • Applying the "source control" model to SUD can enhance treatment efficacy and patient outcomes.
  • This disease-centric perspective can reduce stigma associated with SUD.
  • The model provides a unified approach for acute and long-term management of complex SUD cases.